Trials / Conditions / Stage IV Non-Small Cell Lung Cancer AJCC v7

Stage IV Non-Small Cell Lung Cancer AJCC v7

18 registered clinical trials studyying Stage IV Non-Small Cell Lung Cancer AJCC v7.

Status	Trial	Sponsor	Phase
Completed	Regorafenib and Methotrexate in Treating Participants With Recurrent or Metastatic KRAS Mutated Non-Small Cell NCT03520842	Stanford University	Phase 2
Terminated	Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer NCT03455556	Mayo Clinic	Phase 1
Completed	Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutat NCT03299088	Jonathan Riess	Phase 1
Withdrawn	CPI-613 and Docetaxel in Treating Patients With Stage IIIB or IV Non-small Cell Lung Cancer NCT03370159	Wake Forest University Health Sciences	Phase 1 / Phase 2
Terminated	Collection of Blood Samples in Patients With Non-small Cell Lung Cancer NCT03492801	University of Southern California	—
Completed	Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malig NCT03229278	Rutgers, The State University of New Jersey	Phase 1
Terminated	Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung NCT02846792	University of Washington	Phase 1 / Phase 2
Terminated	Poziotinib in EGFR Exon 20 Mutant Advanced NSCLC NCT03066206	M.D. Anderson Cancer Center	Phase 2
Active Not Recruiting	Nivolumab and Radiation Therapy With or Without Ipilimumab in Treating Patients With Brain Metastases From Non NCT02696993	M.D. Anderson Cancer Center	Phase 1 / Phase 2
Completed	Selumetinib and Paclitaxel as Second-Line Treatment in Treating Patients With Stage IIIB-IV Non-small Cell Lun NCT02503358	OHSU Knight Cancer Institute	Phase 1
Terminated	Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma NCT02408016	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Cabozantinib-S-Malate and Erlotinib Hydrochloride in Treating Patients With Previously Treated Metastatic Non- NCT01866410	National Cancer Institute (NCI)	Phase 2
Completed	Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Can NCT01727076	National Cancer Institute (NCI)	Phase 1
Completed	Surgery and/or Radiation Therapy or Standard Therapy and/or Clinical Observation in Treating Patients With Pre NCT01725165	M.D. Anderson Cancer Center	Phase 2
Completed	Cisplatin and Etoposide With or Without Veliparib in Treating Patients With Extensive Stage Small Cell Lung Ca NCT01642251	National Cancer Institute (NCI)	Phase 1 / Phase 2
Completed	Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Ca NCT00693992	National Cancer Institute (NCI)	Phase 3
Completed	Pemetrexed and/or Sunitinib as Second-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-small NCT00698815	National Cancer Institute (NCI)	Phase 2
Terminated	Radiation Therapy and Stereotactic Radiosurgery With or Without Temozolomide or Erlotinib in Treating Patients NCT00096265	National Cancer Institute (NCI)	Phase 3